Join Y. Luh, MD; Steven E. Finkelstein, MD; Jeff M. Michalski, MD, MBA; Howard Sandler MD, MS
Note: All authors are members of the Prostate Individualized Screening Matters Group.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L17-0734.
Luh JY, Finkelstein SE, Michalski JM, et al. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. Ann Intern Med. 2018;168:607–608. doi: https://doi.org/10.7326/L17-0734
Download citation file:
Published: Ann Intern Med. 2018;168(8):607-608.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use